We are live on ! Find out more
AC

Aldebaran Capital Portfolio holdings

AUM $131M
1-Year Est. Return 34.7%
This Fund
S&P 500
This Quarter Est. Return
-0.26%
1 Year Est. Return
+34.7%
3 Year Est. Return
+72.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$4.33M
Cap. Flow
-$665K
Cap. Flow %
-0.63%
Top 10 Hldgs %
71.81%
Holding
39
New
2
Increased
3
Reduced
25
Closed
2

Top Buys

Rank Stock Value
1
EPIX
ESSA Pharma
EPIX
+$1.27M
2
SIRI icon
SiriusXM
SIRI
+$1.1M
3
ANTX icon
AN2 Therapeutics
ANTX
+$295K
4
PMVP icon
PMV Pharmaceuticals
PMVP
+$101K
5
OKUR
OnKure Therapeutics
OKUR
+$5.45K

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$400K
2
BCIM
abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF
BCIM
+$320K
3
IESC icon
IES Holdings
IESC
+$311K
4
MSFT icon
Microsoft
MSFT
+$310K
5
BG icon
Bunge Global
BG
+$293K

Sector Composition

Rank Sector Weight
1 Financials 28.84%
2 Energy 17.86%
3 Healthcare 13.08%
4 Technology 11.24%
5 Consumer Staples 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
26
PMV Pharmaceuticals
PMVP
$60.3M
$758K 0.72%
502,190
+63,938
+15% +$101K
EPIX
27
DELISTED
ESSA Pharma
EPIX
$712K 0.68%
+397,523
New +$1.27M
TECK icon
28
Teck Resources
TECK
$30.7B
$530K 0.5%
13,085
-228
-2% -$10.7K
ANTX icon
29
AN2 Therapeutics
ANTX
$192M
$474K 0.45%
343,684
+243,184
+242% +$295K
B
30
Barrick Mining
B
$63.2B
$435K 0.41%
28,050
-1,929
-6% -$35.1K
OKUR
31
OnKure Therapeutics
OKUR
$162M
$392K 0.37%
45,572
+360
+0.8% +$5.45K
DUK icon
32
Duke Energy
DUK
$98.4B
$388K 0.37%
3,600
– –
MBIN icon
33
Merchants Bancorp
MBIN
$2.55B
$369K 0.35%
10,125
– –
F icon
34
Ford
F
$59.3B
$254K 0.24%
25,650
– –
OXY.WS icon
35
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$220K 0.21%
7,981
-358
-4% -$10.2K
PG icon
36
Procter & Gamble
PG
$335B
$211K 0.2%
1,260
– –
GE icon
37
GE Aerospace
GE
$368B
$209K 0.2%
1,256
-75
-6% -$13.4K
BCIM
38
DELISTED
abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF
BCIM
– –
-13,272
Closed -$320K
XOM icon
39
ExxonMobil
XOM
$651B
– –
-1,908
Closed -$224K
1
2

Similar funds

CIP
Castlefield Investment Partners Manchester $131M AUM
EIM
Emmett Investment Management New York $131M AUM 25.7% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
LC
LTG Capital Newton, Massachusetts $131M AUM 19.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return
CF
Collier Financial Denver, Colorado $131M AUM
A
AFBI Miami Beach, Florida $131M AUM

Aldebaran Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Aldebaran Capital held 39 positions worth $105M, down 4% from $110M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Aldebaran Capital's Q4 2024 filing shows 2 new, 3 increased, 25 reduced and 2 closed positions. Its largest new stake was ESSA Pharma: 397,523 shares worth $712K. The largest sale was Berkshire Hathaway Class B, an estimated $400K.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Energy and Healthcare.

  • Aldebaran Capital's largest Q4 2024 buy was ESSA Pharma: 397,523 shares worth $712K.
  • Aldebaran Capital added most to AN2 Therapeutics in Q4 2024, an estimated $295K increase.
  • Aldebaran Capital's biggest Q4 2024 reduction was Berkshire Hathaway Class B, cutting an estimated $400K.
  • Aldebaran Capital fully exited abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF in Q4 2024, selling an estimated $320K.
  • Aldebaran Capital's ten largest holdings make up 72% of its $105M portfolio in Q4 2024.
  • Aldebaran Capital opened 2 new positions and closed 2 in Q4 2024.
  • Aldebaran Capital's portfolio value fell 4% quarter-over-quarter to $105M.

Based on Aldebaran Capital's 13F filing for Q4 2024, filed 12 Feb 2025.